| RS1569042640 |
TRIOBP
|
Health Risk |
Pathogenic |
— |
| RS1569042693 |
TRIOBP
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 28, Autosomal recessive nonsyndromic hearing loss 28 |
| RS1569042782 |
TRIOBP
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 28, Hearing loss |
| RS1569044747 |
IL2RB
|
Health Risk |
Pathogenic |
Ichthyosis, Ichthyosis |
| RS1569044884 |
TBX4
|
Health Risk |
Pathogenic |
Coxopodopatellar syndrome, Coxopodopatellar syndrome |
| RS1569046250 |
TRIOBP
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 28, Autosomal recessive nonsyndromic hearing loss 28 |
| RS1569046598 |
TBX4
|
Health Risk |
Pathogenic |
Coxopodopatellar syndrome, Coxopodopatellar syndrome |
| RS1569049136 |
TRIOBP
|
Health Risk |
Likely pathogenic |
— |
| RS1569050345 |
SON
|
Health Risk |
Likely pathogenic |
ZTTK syndrome, ZTTK syndrome |
| RS1569052840 |
SON
|
Health Risk |
Pathogenic |
— |
| RS1569053308 |
SON
|
Health Risk |
Pathogenic |
ZTTK syndrome, ZTTK syndrome |
| RS1569054086 |
CHKB
|
Health Risk |
Pathogenic |
Megaconial type congenital muscular dystrophy, Megaconial type congenital muscular dystrophy |
| RS1569054508 |
CHKB
|
Health Risk |
Pathogenic |
Megaconial type congenital muscular dystrophy, Megaconial type congenital muscular dystrophy |
| RS1569055781 |
SON
|
Health Risk |
Pathogenic |
ZTTK syndrome, ZTTK syndrome |
| RS1569056484 |
SON
|
Health Risk |
Likely pathogenic |
ZTTK syndrome, ZTTK syndrome |
| RS1569057333 |
SON
|
Health Risk |
Likely pathogenic |
ZTTK syndrome, ZTTK syndrome |
| RS1569057837 |
FRMPD4
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 104 |
| RS1569058041 |
SON
|
Health Risk |
Likely pathogenic |
ZTTK syndrome, ZTTK syndrome |
| RS1569058837 |
SON
|
Health Risk |
Pathogenic |
— |
| RS1569059249 |
ANOS1
|
Health Risk |
Likely pathogenic |
— |
| RS1569059792 |
SON
|
Health Risk |
Pathogenic |
ZTTK syndrome, ZTTK syndrome |
| RS1569060096 |
TRMU
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1569061762 |
RUNX1
|
Health Risk |
Pathogenic |
Thrombocytopenia, Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1 |
| RS1569061768 |
RUNX1
|
Health Risk |
Likely pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Thrombocytopenia |
| RS1569061786 |
RUNX1
|
Health Risk |
Likely pathogenic |
Hereditary thrombocytopenia and hematologic cancer predisposition syndrome, Thrombocytopenia |
| RS1569061799 |
RUNX1
|
Health Risk |
Likely pathogenic |
Hereditary thrombocytopenia and hematologic cancer predisposition syndrome, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS1569061831 |
RUNX1
|
Health Risk |
Pathogenic |
Hereditary thrombocytopenia and hematologic cancer predisposition syndrome, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS1569064110 |
GRIN2D
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 46 |
| RS1569065861 |
GRIN2D
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 46 |
| RS1569065866 |
GRIN2D
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 46 |
| RS1569067939 |
DEPDC5
|
Health Risk |
Pathogenic |
Epilepsy, familial focal |
| RS1569069402 |
ERG
|
Health Risk |
Pathogenic |
Lymphatic malformation 14, Lymphatic malformation 14 |
| RS1569071931 |
HPS4
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 4, Hermansky-Pudlak syndrome 4 |
| RS1569072024 |
MCM3AP
|
Health Risk |
Pathogenic |
Peripheral neuropathy, autosomal recessive |
| RS1569072157 |
TRMU
|
Health Risk |
Likely pathogenic |
Aminoglycoside-induced deafness, Aminoglycoside-induced deafness |
| RS1569073058 |
MCM3AP
|
Health Risk |
Pathogenic |
Peripheral neuropathy, autosomal recessive |
| RS1569074977 |
MCM3AP
|
Health Risk |
Pathogenic |
Peripheral neuropathy, autosomal recessive |
| RS1569074992 |
MCM3AP
|
Health Risk |
Pathogenic |
Peripheral neuropathy, autosomal recessive |
| RS1569075471 |
SYNJ1
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 1 |
| RS1569077009 |
CSNK1E
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 1 |
| RS1569077441 |
IFT27
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 19 |
| RS1569077723 |
ARSA
|
Health Risk |
Pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS1569078774 |
RUNX1
|
Health Risk |
Pathogenic |
Hereditary thrombocytopenia and hematologic cancer predisposition syndrome, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS1569078784 |
RUNX1
|
Health Risk |
Likely pathogenic |
Hereditary thrombocytopenia and hematologic cancer predisposition syndrome, Pancytopenia |
| RS1569078799 |
RUNX1
|
Health Risk |
Pathogenic |
Hereditary thrombocytopenia and hematologic cancer predisposition syndrome, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS1569079076 |
RUNX1
|
Health Risk |
Pathogenic |
Hereditary thrombocytopenia and hematologic cancer predisposition syndrome, Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1 |
| RS1569081077 |
ARSA
|
Health Risk |
Likely pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS1569081805 |
TRMU
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1569081823 |
ARSA
|
Health Risk |
Pathogenic/Likely pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS1569082469 |
ARSA
|
Health Risk |
Pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS1569082621 |
ARSA
|
Health Risk |
Pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS1569083185 |
FANCB
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group B, Fanconi anemia complementation group B |
| RS1569083464 |
FANCB
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group B, Fanconi anemia complementation group B |
| RS1569083500 |
DEPDC5
|
Health Risk |
Likely pathogenic |
Epilepsy, familial focal |
| RS1569083679 |
FANCB
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group B, Fanconi anemia complementation group B |
| RS1569084032 |
RUNX1
|
Health Risk |
Likely pathogenic |
Hereditary thrombocytopenia and hematologic cancer predisposition syndrome, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS1569084082 |
RUNX1
|
Health Risk |
Likely pathogenic |
Hereditary thrombocytopenia and hematologic cancer predisposition syndrome, Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1 |
| RS1569084106 |
RUNX1
|
Health Risk |
Likely pathogenic |
Thrombocytopenia, Acute myeloid leukemia |
| RS1569084116 |
RUNX1
|
Health Risk |
Likely pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, RUNX1-related disorder |
| RS1569084170 |
RUNX1
|
Health Risk |
Pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Acute myeloid leukemia |
| RS1569084388 |
RUNX1
|
Health Risk |
Pathogenic |
Hereditary thrombocytopenia and hematologic cancer predisposition syndrome, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS1569084451 |
RUNX1
|
Health Risk |
Pathogenic |
Hereditary thrombocytopenia and hematologic cancer predisposition syndrome, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS1569084530 |
RUNX1
|
Health Risk |
Pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS1569084646 |
RUNX1
|
Health Risk |
Pathogenic |
Hereditary thrombocytopenia and hematologic cancer predisposition syndrome, Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1 |
| RS1569085428 |
MCM3AP
|
Health Risk |
Pathogenic |
— |
| RS1569085580 |
RTEL1
|
Health Risk |
Likely pathogenic |
Dyskeratosis congenita, autosomal recessive 5 |
| RS1569085810 |
FANCB
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group B, Fanconi anemia complementation group B |
| RS1569086116 |
SYNJ1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 53 |
| RS1569086477 |
MCM3AP
|
Health Risk |
Pathogenic |
Peripheral neuropathy, autosomal recessive |
| RS1569090318 |
EP300
|
Health Risk |
Conflicting classifications of pathogenicity |
Rubinstein-Taybi syndrome due to EP300 haploinsufficiency, EP300-related disorder |
| RS1569090642 |
EP300
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to EP300 haploinsufficiency, Rubinstein-Taybi syndrome due to EP300 haploinsufficiency |
| RS1569090870 |
RTEL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pulmonary fibrosis and/or bone marrow failure, Telomere-related |
| RS1569096551 |
ADSL
|
Health Risk |
Pathogenic |
Adenylosuccinate lyase deficiency, Adenylosuccinate lyase deficiency |
| RS1569097392 |
SHANK3
|
Health Risk |
Pathogenic/Likely pathogenic |
Seizure, Global developmental delay |
| RS1569099793 |
ADSL
|
Health Risk |
Pathogenic |
Adenylosuccinate lyase deficiency, Adenylosuccinate lyase deficiency |
| RS1569100177 |
RIPK4
|
Health Risk |
Pathogenic |
Bartsocas-Papas syndrome 1, Bartsocas-Papas syndrome 1 |
| RS1569102786 |
OFD1
|
Health Risk |
Likely pathogenic |
Joubert syndrome, Orofaciodigital syndrome I |
| RS1569104011 |
CHEK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Malignant tumor of breast |
| RS1569107391 |
EP300
|
Health Risk |
Pathogenic |
— |
| RS1569108381 |
EP300
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to EP300 haploinsufficiency, Rubinstein-Taybi syndrome due to EP300 haploinsufficiency |
| RS1569109423 |
TUBGCP6
|
Health Risk |
Pathogenic |
— |
| RS1569110700 |
TCF20
|
Health Risk |
Pathogenic |
Autistic behavior, Hypotonia |
| RS1569111699 |
CHEK2
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS1569112324 |
CHEK2
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS1569112355 |
LARGE1
|
Health Risk |
Likely pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A6 |
| RS1569112557 |
CHEK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1569113445 |
TLR8
|
Health Risk |
association |
Osteoarthritis, Osteoarthritis |
| RS1569113447 |
TLR8
|
Health Risk |
association |
Osteoarthritis, Osteoarthritis |
| RS1569113653 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS1569114113 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS1569115687 |
CHEK2
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Malignant lymphoma |
| RS1569115756 |
SHANK3
|
Health Risk |
Pathogenic |
Phelan-McDermid syndrome, Phelan-McDermid syndrome |
| RS1569116167 |
SHANK3
|
Health Risk |
Likely pathogenic |
— |
| RS1569116316 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS1569116595 |
SHANK3
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1569118537 |
EP300
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to EP300 haploinsufficiency, Colorectal carcinoma |
| RS1569118680 |
NLGN4X
|
Health Risk |
Pathogenic; risk factor |
Autism, susceptibility to |
| RS1569118851 |
GPR143
|
Health Risk |
Pathogenic |
Nystagmus 6, congenital |
| RS1569118853 |
NLGN4X
|
Health Risk |
risk factor |
Autism, susceptibility to |
| RS1569119395 |
WNT7B
|
Health Risk |
Pathogenic |
Matthew-Wood syndrome, See cases |